The funding will accelerate Moderna’s work on a pandemic influenza vaccine, particularly against H5N1 bird flu, enhancing public health safety amid rising infections.
Outgoing HHS Secretary Xavier Becerra emphasized that "Accelerating the development of new vaccines will allow us to stay ahead and ensure that Americans have the tools they need to stay safe."
The urgency of the situation is underscored by the rapid spread of bird flu in the U.S., bringing attention to its unpredictability and potential threat.
With $590 million from HHS, Moderna aims to advance late-stage development and licensure of vaccines against pandemic influenza, addressing looming public health emergencies.
Collection
[
|
...
]